DC FUNDS, LP TScan Therapeutics, Inc. Transaction History

DC FUNDS, LP portfolio value:

$1.92M
portfolio value

DC FUNDS, LP quarter portfolio value change:

-3.02%
quarter

TScan Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -59K $3.05 630K
Q2 2022 share 0.00% 0 shares 217K $3.15 630K
Q1 2022 share 0.00% 0 shares -1.07M $2.8 630K
Q4 2021 share 0.00% 0 shares -2.41M $4.83 630K
Q3 2021 share Increase 0.00% 630K shares 5.25M $8.34 630K